| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratoire d'Hématologie-Cytologie-Immunopathologie, Ecole Nationale Vétérinaire de Lyon, France (CF, FP, AB, CB, LC, TM, JLC, IGT, DL, IG, JPM); and Laboratoire d'Hématologie Cellulaire, Centre hospitalier Lyon-Sud, France (PF)
The aim of this study is to report 46 new cases of canine T-cell lymphomas among a series of 140 lymphomas studied by immunophenotyping (incidence 32.8%). According to the updated Kiel classification adapted to the canine species, 13 were classified as low-grade and 33 as high-grade lymphomas. Among the low-grade lymphomas, five were small clear-cell lymphomas, three were pleomorphic small-cell lymphomas, and five mycosis fungoides. Among the high-grade cases, there were 11 pleomorphic mixed-, small-, and large-cell lymphomas, 6 pleomorphic large-cell lymphomas, 11 lymphoblastic lymphomas, and 5 unclassifiable high-grade plasmacytoid lymphomas. The cytohistologic features were highly suggestive of a T-cell phenotype on the basis of cell morphology (irregular nuclei and clear cytoplasms) (30/46 cases), a T-cell zone pattern, and the presence of hyperplastic postcapillary venules (22/46 cases). All 46 cases were CD3+ CD79a-, and among 34 cases investigated for CD4 and CD8 expression, 13 were CD4+CD8-, 13 were CD8+CD4-, and 8 were CD4CD8 double positive or double negative. The pleomorphic mixed lymphomas were mainly CD4+CD8- (6/7) and the lymphoblastic lymphomas were double positive or double negative (6/8). The main clinical, hematologic, and biochemical features were generalized (28/46) or regional lymphadenopathy (16/46), hepatosplenomegaly (15/46), extranodal involvement (11/46), mediastinal mass (9/46), and leukemia (8/46), which were mainly present in cases of lymphoblastic lymphomas and hypercalcemia (16/46).
Key words: Canine; classification; immunophenotyping; malignant lymphoma; T-cell lymphoma.
Request reprints from Corinne Fournel-Fleury, Ecole Nationale Vétérinaire de Lyon, Laboratoire d'Hématologie-Cytologie-Immunopathologie, Service de Médecine, 1, av. Bourgelat BP 83-69280, Marcy-L'Etoile (France). E-mail: c.fournel{at}vet-lyon.fr.
This article has been cited by other articles:
![]() |
C. Thuilliez, D. Watrelot-Virieux, F. Chanut, C. Fournel-Fleury, F. Ponce, and T. Marchal Presumed primary muscular lymphoma in a dog J Vet Diagn Invest, November 1, 2008; 20(6): 824 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tzannes, P. Ibarrola, D. J. Batchelor, R. D. Burrow, and L. Blackwood Use of Recombinant Human Interferon Alpha-2a in the Management of a Dog With Epitheliotropic Lymphoma J. Am. Anim. Hosp. Assoc., September 1, 2008; 44(5): 276 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Valli, W. Vernau, L.-P de Lorimier, P. S. Graham, and P. F. Moore Canine Indolent Nodular Lymphoma Vet. Pathol., May 1, 2006; 43(3): 241 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Jubala, J. W. Wojcieszyn, V. E. O. Valli, D. M. Getzy, S. P. Fosmire, D. Coffey, D. Bellgrau, and J. F. Modiano CD20 Expression in Normal Canine B Cells and in Canine non-Hodgkin Lymphoma Vet. Pathol., July 1, 2005; 42(4): 468 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Coyle and H. Steinberg Characterization of Lymphocytes in Canine Gastrointestinal Lymphoma Vet. Pathol., March 1, 2004; 41(2): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |